[vanderzapig]

De chronologie van dit soort nieuwsberichten doet mij naar mijn hoedje van aluminiumfolie grijpen:

6 oktober 2021:

Aspirin lowers risk of COVID: New findings support preliminary Israeli trial

Over-the-counter aspirin could protect the lungs of COVID-19 patients and minimize the need for mechanical ventilation, according to new research at the George Washington University.

The team investigated more than 400 COVID patients from hospitals across the United States who take aspirin unrelated to their COVID disease, and found that the treatment reduced the risk of several parameters by almost half: reaching mechanical ventilation by 44%, ICU admissions by 43%, and overall in-hospital mortality by 47%.

“As we learned about the connection between blood clots and COVID-19, we knew that aspirin – used to prevent stroke and heart attack – could be important for COVID-19 patients,” said Dr. Jonathan Chow of the study team. “Our research found an association between low-dose aspirin and decreased severity of COVID-19 and death.”

13 oktober 2021:

US task force proposes adults 60 and older should not start daily aspirin to prevent heart disease or stroke

The draft also says that adults 60 and older should not start taking aspirin to prevent heart disease and stroke because new evidence shows that potential harms cancel out the benefits, according to the task force.

"The latest evidence is clear: starting a daily aspirin regimen in people who are 60 or older to prevent a first heart attack or stroke is not recommended," Task Force member Dr. Chien-Wen Tseng said in a statement.